- Home
- / Cizzle Biotechnology Holdings
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Cizzle Biotechnology Holdings financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
£0
2024-10-29
Market Capitalization
£8.3 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 20, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 207.0K | |||||||
| Cost of goods sold | 29.0K | |||||||
| Gross profit | 232.0K | 82.0K | 2.0K | |||||
| Gross profit margin, % | 112.1% | |||||||
| Operating expense total | 828.0K | 631.0K | 306.0K | 4.0M | 826.0K | 905.0K | 779.0K | 617.0K |
| Depreciation and amortization | 624.0K | |||||||
| EBITDA | (596.0K) | (631.0K) | (306.0K) | (4.0M) | (826.0K) | (1.0M) | (697.0K) | (615.0K) |
| EBITDA margin, % | -287.9% | |||||||
| EBIT | (1.2M) | (832.0K) | (306.0K) | (4.0M) | (826.0K) | (981.0K) | (697.0K) | (615.0K) |
| EBIT margin, % | -589.4% | |||||||
| Interest expense | 26.0K | |||||||
| Pre tax profit | (1.7M) | (832.0K) | (306.0K) | (4.0M) | (963.0K) | (1.8M) | (2.2M) | (751.0K) |
| Income tax expense | (118.0K) | (37.0K) | (51.0K) | (46.0K) | (21.0K) | (60.0K) | ||
| Net Income | (1.6M) | (832.0K) | (306.0K) | (3.9M) | (912.0K) | (1.7M) | (2.2M) | (691.0K) |